KPC Pharmaceuticals Inc Cash Flow Reinvestment Rate
KPC Pharmaceuticals Inc cash flow reinvestment rate. KPC Pharmaceuticals Inc (600422) has a Cash Flow Reinvestment Rate of 7.94x as of December 2025, reinvesting CN¥898.19 Million (capex CN¥32.53 Million plus investments CN¥865.66 Million) from operating cash flow of CN¥113.07 Million. Explore KPC Pharmaceuticals Inc (600422) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of KPC Pharmaceuticals Inc (1999–2025)
Cash flow reinvestment rate of KPC Pharmaceuticals Inc from 1999 to 2025. Historical reinvestment intensity for KPC Pharmaceuticals Inc across 25 annual periods. Explore capital reinvestment ratio of KPC Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.
KPC Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (1999–2025)
KPC Pharmaceuticals Inc cash flow reinvestment rate by year from 1999 to 2025. Year-by-year capital reinvestment analysis for KPC Pharmaceuticals Inc. For the full cash flow conversion analysis, see 600422 cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.22x | CN¥642.88 Million | CN¥289.24 Million | CN¥90.56 Million | ▲ +633.6% |
| 2024 | 0.30x | CN¥244.84 Million | CN¥808.07 Million | CN¥79.43 Million | ▼ -49.1% |
| 2023 | 0.60x | CN¥448.86 Million | CN¥754.33 Million | CN¥109.64 Million | ▼ -55.1% |
| 2022 | 1.32x | CN¥336.35 Million | CN¥253.90 Million | CN¥101.75 Million | ▼ -25.1% |
| 2021 | 1.77x | CN¥444.88 Million | CN¥251.63 Million | CN¥236.17 Million | ▲ +219.0% |
| 2020 | 0.55x | CN¥227.19 Million | CN¥409.94 Million | CN¥158.73 Million | ▼ -56.1% |
| 2019 | 1.26x | CN¥541.78 Million | CN¥429.50 Million | CN¥347.35 Million | ▼ -32.1% |
| 2018 | 1.86x | CN¥654.55 Million | CN¥352.07 Million | CN¥217.26 Million | ▲ +40.2% |
| 2017 | 1.33x | CN¥321.69 Million | CN¥242.53 Million | CN¥268.74 Million | ▲ +75.0% |
| 2016 | 0.76x | CN¥235.78 Million | CN¥311.16 Million | CN¥203.45 Million | ▼ -77.4% |
| 2015 | 3.35x | CN¥1.60 Billion | CN¥476.62 Million | CN¥210.82 Million | ▲ +469.8% |
| 2014 | 0.59x | CN¥222.98 Million | CN¥379.13 Million | CN¥222.98 Million | ▼ -33.1% |
| 2013 | 0.88x | CN¥212.65 Million | CN¥241.97 Million | CN¥212.65 Million | ▲ +52.2% |
| 2012 | 0.58x | CN¥123.22 Million | CN¥213.33 Million | CN¥123.22 Million | ▲ +89.0% |
| 2011 | 0.31x | CN¥42.85 Million | CN¥140.24 Million | CN¥42.85 Million | ▼ -56.7% |
| 2010 | 0.71x | CN¥64.16 Million | CN¥90.82 Million | CN¥64.16 Million | ▲ +382.6% |
| 2009 | 0.15x | CN¥18.82 Million | CN¥128.57 Million | CN¥18.82 Million | ▲ +2.4% |
| 2008 | 0.14x | CN¥13.09 Million | CN¥91.59 Million | CN¥13.09 Million | ▲ +11.5% |
| 2007 | 0.13x | CN¥16.67 Million | CN¥130.06 Million | CN¥16.67 Million | ▼ -73.0% |
| 2006 | 0.47x | CN¥29.03 Million | CN¥61.25 Million | CN¥29.03 Million | ▼ -9.5% |
| 2003 | 0.52x | CN¥32.08 Million | CN¥61.23 Million | CN¥32.08 Million | ▼ -88.6% |
| 2002 | 4.58x | CN¥79.62 Million | CN¥17.38 Million | CN¥79.62 Million | ▲ +1594.6% |
| 2001 | 0.27x | CN¥18.13 Million | CN¥67.07 Million | CN¥18.13 Million | ▼ -46.7% |
| 2000 | 0.51x | CN¥24.20 Million | CN¥47.76 Million | CN¥24.20 Million | ▲ +141.1% |
| 1999 | 0.21x | CN¥12.67 Million | CN¥60.24 Million | CN¥12.67 Million | — |